Medicore Co., Ltd. (CEO Cho Young-shin) announced that it will participate in the 3th International Medical Equipment and Hospital Equipment Exhibition ‘KIMES 23’, which will be held at COEX, Seoul from March 26rd (Thursday) to 38th (Sunday).
Medicore is a medical device manufacturing company that has been devoted to the autonomic nerve and vascular health testing and thermodiagnosis markets since its establishment in 1999. Regarding autonomic nerve testing, we conducted clinical research with university hospitals, established heart rate variability standards for Asians, and received patents in Japan and Korea. We also published an SCI-level paper related to the product.
Currently, we are exporting our products to global markets such as Japan, China, the United States, and Europe. We are discovering overseas medical device distributors and utilizing local sales networks, and through this, we are securing distribution channels in areas where Medicore products can be used, such as university hospitals, doctors, research institutes, and government offices. The official explains that they also have a lot of experience with strategic business models such as the insurance market and MLM collaboration.
The main product to be introduced at this exhibition is ‘SA-3000P’, a cardiovascular measurement medical device that can simultaneously perform autonomic balance tests and arterial blood vessel health tests. The medical device measures heart rate variability to measure the balance of the sympathetic nervous system and parasympathetic nervous system, and based on this, mental and physical stress index and stress resilience. ) is presented as a numerical value.
In addition, references by age, gender, and race are applied to show whether the sympathetic and parasympathetic nerves are within the normal range according to the patient’s condition. APG Pulse Wave shows the aging index of blood vessels, arterial vessel elasticity, and peripheral vessel elasticity, and divides the state of blood vessels into 1 to 7 to determine where they belong. It tells you.
Medicore said, “Through KIMES 2023, we plan to discover potential domestic customers and solidify our position, and externally, we plan to discover potential overseas distributors and utilize our local sales network.”
Additionally, “We plan to add more accurate indicators to measure blood circulation in the future. “As a result, we can strengthen the analysis of cardiovascular diseases such as arteriosclerosis, and we plan to add parameters that can measure blood ejection, vasodilation, and vein health in more detail.”
On the other hand, KIMES is an exhibition specializing in medical devices and hospital facilities that has grown steadily with the development of the Korean medical industry since its first meeting in 1980. It has transformed into a technology-intensive high-tech industry such as rehabilitation medicine.
KIMES 2023 will feature new technologies and new products suitable for the era of convergence, such as smart healthcare in the era of the 4th Industrial Revolution, robotic medicine and eco-friendly medical waste facilities, cutting-edge hospital facilities, medical information systems combined with IT technology, and the automobile industry for rapid patient transportation. presents. In addition, it provides a variety of information, including seminars on medical technology, new technology, and overseas marketing, as well as domestic medical industry policy seminars that will show the latest information and direction of the medical industry.